Suppr超能文献

含裸盖菇素的蘑菇:精神病学、生物医学和营养保健领域中一个快速发展的生物技术产业。

Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.

作者信息

Strauss Dominique, Ghosh Soumya, Murray Zurika, Gryzenhout Marieka

机构信息

Department of Genetics, Natural and Agricultural Sciences, University of Free State, PO Box 339, Bloemfontein, 9301 South Africa.

出版信息

3 Biotech. 2022 Dec;12(12):339. doi: 10.1007/s13205-022-03355-4. Epub 2022 Nov 4.

Abstract

Humans have collected and used hallucinogenic mushrooms for ethnic medicinal, recreational, and religious purposes since before recorded history. Currently, the use of these mushrooms is illegal in most countries, but where their use is legal they are applied as self medication. Psilocybin and psilocin, two psychoactive alkaloids, are naturally synthesized by hallucinogenic mushrooms. The chemical structure of these compounds are similar to the neurotransmitter serotonin. Activation of this system by psilocybin and psilocin may produce temporary changes in the brain that induce hallucinations and feelings of euphoria. Adjustment of the serotonin system in this way can moderate symptoms of related mental disorders. This review summarizes relevant and current information regarding the discovery of hallucinogenic mushrooms and their contained psychoactive compounds, the events that lead to their criminalization and decriminilization, and the state of knowledge of psilocybin, psilocin, and derivatives. Last, research on the psychoactive properties of these mushrooms is placed in perspective to possible applications for human dysfunctions.

摘要

自历史记载之前起,人类就已采集并使用致幻蘑菇用于民族医药、娱乐及宗教目的。目前,在大多数国家,使用这些蘑菇是非法的,但在其使用合法的地方,它们被用作自我治疗药物。裸盖菇素和脱磷酸裸盖菇素这两种精神活性生物碱是由致幻蘑菇自然合成的。这些化合物的化学结构与神经递质血清素相似。裸盖菇素和脱磷酸裸盖菇素对该系统的激活可能会在大脑中产生暂时变化,从而诱发幻觉和欣快感。以这种方式调节血清素系统可以缓解相关精神障碍的症状。本综述总结了有关致幻蘑菇及其所含精神活性化合物的发现、导致其被定罪和非刑事化的事件以及裸盖菇素、脱磷酸裸盖菇素及其衍生物的知识现状的相关及最新信息。最后,对这些蘑菇精神活性特性的研究与人类功能障碍的可能应用进行了展望。

相似文献

2
[Hallucinogenic mushrooms].
Medicina (Kaunas). 2005;41(12):1067-70.
4
Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms.
J Pharm Biomed Anal. 2020 Oct 25;190:113485. doi: 10.1016/j.jpba.2020.113485. Epub 2020 Jul 21.
5
DNA Authentication and Chemical Analysis of Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites.
Appl Environ Microbiol. 2022 Dec 20;88(24):e0149822. doi: 10.1128/aem.01498-22. Epub 2022 Nov 29.
7
Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance.
Drug Metab Rev. 2017 Feb;49(1):84-91. doi: 10.1080/03602532.2016.1278228. Epub 2017 Jan 31.
8
Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.
CNS Spectr. 2023 Aug;28(4):416-426. doi: 10.1017/S1092852922000888. Epub 2022 Jul 11.
10
Hallucinogenic mushrooms on the German market - simple instructions for examination and identification.
Forensic Sci Int. 2000 Sep 11;113(1-3):389-95. doi: 10.1016/s0379-0738(00)00211-5.

引用本文的文献

1
Exploring Strains: Cultivation Techniques, Psychoactive Compounds, Genetics and Research Gaps.
J Fungi (Basel). 2025 Jan 28;11(2):99. doi: 10.3390/jof11020099.
2
Global species diversity and distribution of the psychedelic fungal genus .
Heliyon. 2023 May 18;9(6):e16338. doi: 10.1016/j.heliyon.2023.e16338. eCollection 2023 Jun.

本文引用的文献

1
Increased low-frequency brain responses to music after psilocybin therapy for depression.
J Affect Disord. 2023 Jul 15;333:321-330. doi: 10.1016/j.jad.2023.04.081. Epub 2023 Apr 23.
2
Genetic Survey of Psilocybe Natural Products.
Chembiochem. 2022 Jul 19;23(14):e202200249. doi: 10.1002/cbic.202200249. Epub 2022 Jun 9.
3
Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.
Fungal Biol. 2022 Apr;126(4):308-319. doi: 10.1016/j.funbio.2022.01.003. Epub 2022 Feb 11.
4
The therapeutic potential of psilocybin: a systematic review.
Expert Opin Drug Saf. 2022 Jun;21(6):833-840. doi: 10.1080/14740338.2022.2047929. Epub 2022 Mar 2.
5
The Rapid Rise in Investment in Psychedelics-Cart Before the Horse.
JAMA Psychiatry. 2022 Mar 1;79(3):189-190. doi: 10.1001/jamapsychiatry.2021.3972.
6
Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.
Acta Crystallogr C Struct Chem. 2022 Jan 1;78(Pt 1):36-55. doi: 10.1107/S2053229621013164.
8
Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.
J Affect Disord. 2022 Jan 1;296:26-34. doi: 10.1016/j.jad.2021.09.041. Epub 2021 Sep 17.
10
The Therapeutic Potential of Psilocybin.
Molecules. 2021 May 15;26(10):2948. doi: 10.3390/molecules26102948.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验